Balanced news tone
News Sentiment
BGT sentiment intelligence
Bio-Gene Technology Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, -22.7% over four weeks, trend inactive, and below fair value.
Enterprise value to revenue forward of Bio-Gene Technology Ltd. – ASX:BGT
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to revenue forward of Bio-Gene Technology Ltd. – ASX:BGT
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 02:05
- Source
- TradingView
Bio-Gene Technology (ASX:BGT) Moves Ahead With Strategic Funding Initiative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Kalkine
Why Are Investors Cautious On Bellevue Gold (ASX:BGT) Stock Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Kalkine
Bio-Gene Technology (ASX: BGT) Reports Flavocide® Tick Control Data from Purdue Study, Shares up 38%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2025 07:00
- Source
- Kalkine
BGT Stock Price and Chart — ASX:BGT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Dec 2017 21:44
- Source
- TradingView